Assembly Biosciences
ASMB
36 hedge funds and large institutions have $140M invested in Assembly Biosciences in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
77% more capital invested
Capital invested by funds: $79.4M → $140M (+$60.9M)
5.64% more ownership
Funds ownership: 0% → 5.64% (+5.6%)
0% more funds holding
Funds holding: 36 → 36 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
76% less call options, than puts
Call options by funds: $150K | Put options by funds: $634K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$8.21M |
| 2 |
Jennison Associates
New York
|
+$592K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$234K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$207K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$785K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$542K |
| 3 |
QF
QVT Financial
New York
|
-$198K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$174K |
| 5 |
Goldman Sachs
New York
|
-$165K |
ASMB Hedge Fund Activity: Q4 2016 in Review
36 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2016, worth a combined $140M — up 77% from $79.4M a quarter earlier.
Fund positioning in ASMB was balanced in Q4 2016: 7 funds opened new positions, 7 closed out, 10 added to existing stakes and 10 trimmed.
The largest buyer was Acuta Capital Partners, adding an estimated $8.21M. The largest seller was Perceptive Advisors, cutting an estimated $785K.
- 36 institutional investors held Assembly Biosciences (ASMB) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $140M of Assembly Biosciences stock for Q4 2016, up 77% quarter-over-quarter.
- 7 funds opened new Assembly Biosciences positions in Q4 2016 and 7 closed out, a net change of 0 holders.
- The largest Assembly Biosciences buyer in Q4 2016 was Acuta Capital Partners, an estimated $8.21M added.
- The largest Assembly Biosciences seller in Q4 2016 was Perceptive Advisors, an estimated $785K sold.
Based on aggregated 13F filings for Q4 2016.